Works matching IS 10781552 AND DT 2018 AND VI 24 AND IP 8

Results: 12

A case of aseptic meningitis in a cetuximab-experienced patient with metastatic colon cancer.

Published in:

Journal of Oncology Pharmacy Practice, 2018, v. 24, n. 8, p. 632, doi. 10.1177/1078155217739685

By:

Rohrer, Chelsea L.;
Grullon, Zunilda;
George, Sarah K.;
Castillo, Raul;
Karasiewicz, Kelli

Publication type:

Article

Sirolimus and mirabegron interaction in a hematopoietic cell transplant patient.

Published in:

Journal of Oncology Pharmacy Practice, 2018, v. 24, n. 8, p. 627, doi. 10.1177/1078155217726161

By:

Engle, Jeff A.;
Fair, Christina

Publication type:

Article

Severe sunitinib-induced myelosuppression in a patient with a CYP 3A4 polymorphism.

Published in:

Journal of Oncology Pharmacy Practice, 2018, v. 24, n. 8, p. 623, doi. 10.1177/1078155217724863

By:

Patel, Nirav D.;
Chakrabory, Kanishka;
Krishnan, Koyamangalath;
Messmer, Garrett;
Bossaer, John B.

Publication type:

Article

Start using a checklist, PRONTO: Recommendation for a standard review process for chemotherapy orders.

Published in:

Journal of Oncology Pharmacy Practice, 2018, v. 24, n. 8, p. 609, doi. 10.1177/1078155217722594

By:

Crandell, Brian C.;
Bates, Jill S.;
Grgic, Tatjana

Publication type:

Article

Making moves: Transitioning R-EPOCH to the ambulatory setting.

Published in:

Journal of Oncology Pharmacy Practice, 2018, v. 24, n. 8, p. 617, doi. 10.1177/1078155217722408

By:

Martin, Allison L.;
Frank, Joel P.;
Waggoner, Mindy L.

Publication type:

Article

Retrospective analysis of goal drug level attainment of posaconazole for invasive fungal infection prophylaxis in patients with acute myeloid leukemia pre- and post-switch to tablet formulation.

Published in:

Journal of Oncology Pharmacy Practice, 2018, v. 24, n. 8, p. 599, doi. 10.1177/1078155217722405

By:

Liebenstein, Tyler K.;
Widmer, Kristin M.;
Fallon, Michael J.

Publication type:

Article

Dapsone and azole interactions: A clinical perspective.

Published in:

Journal of Oncology Pharmacy Practice, 2018, v. 24, n. 8, p. 637, doi. 10.1177/1078155217722048

By:

Corallo, Carmela;
Coutsouvelis, John;
Avery, Sharon;
Morgan, Susan;
Morrissey, Orla

Publication type:

Article

A deliberative framework to identify the need for real-life evidence building of new cancer drugs after interim funding decision.

Published in:

Journal of Oncology Pharmacy Practice, 2018, v. 24, n. 8, p. 584, doi. 10.1177/1078155217722047

By:

Leung, Leanne;
de Lemos, Mário L.;
Kovacic, Laurel

Publication type:

Article

Evaluation of pegfilgrastim use at an academic medical center.

Published in:

Journal of Oncology Pharmacy Practice, 2018, v. 24, n. 8, p. 604, doi. 10.1177/1078155217722046

By:

Tang, Kathy;
Duffy, Alison;
Gilmore, Steven

Publication type:

Article

An evaluation of chemotherapy drug preparation process in hospitals in Turkey – A pilot study.

Published in:

Journal of Oncology Pharmacy Practice, 2018, v. 24, n. 8, p. 563, doi. 10.1177/1078155217720007

By:

Bayraktar-Ekincioglu, Aygin;
Demirkan, Kutay;
Korubük, Gamze

Publication type:

Article

Loperamide and cardiac events: Is high-dose use still safe for chemotherapy-induced diarrhea?

Published in:

Journal of Oncology Pharmacy Practice, 2018, v. 24, n. 8, p. 634, doi. 10.1177/1078155217718384

By:

de Lemos, Mário L.;
Kletas, Victoria;
Guenter, Jolene

Publication type:

Article

Real-world chart review study of adverse events management in patients taking tyrosine kinase inhibitors to treat metastatic renal cell carcinoma.

Published in:

Journal of Oncology Pharmacy Practice, 2018, v. 24, n. 8, p. 574, doi. 10.1177/1078155217719583

By:

Srinivas, Sandy;
Stein, Dara;
Tao, Sunning;
Teltsch, Dana Y.;
Cisar, Laura;
Ramaswamy, Krishnan

Publication type:

Article